Determination of effects of transgenic Cblin peptide-enriched
rice on mice with sciatic denervation
Six-week-old male Jcl:ICR mice (Japan SLC Inc., Shizuoka, Japan) were
housed with access to a standard diet and water ad libitum under lights
on from 8 a.m. to 8.0 p.m. The experimental diet comprised powdered
Cblin rice grains (CbR) and non-transgenic rice (non-Tg) mixed with the
standard diet (50% w/w). Supplementary Table 2 shows the composition
of the diets. The mice were then fed with the diet containing either CbR or
non-Tg for 7 days, then their sciatic nerves were unilaterally transected
under anesthesia. The contralateral innervated (sham-operated) muscles
of the same animals served as controls. Seven days later, the mice were
sacrificed and the Sol and Ga muscles were dissected, weighed, and
frozen in liquid nitrogen.
All animal experiments proceeded according to the guidelines for
animal experiments at Tokushima University and Kyushu University. The
Ethics Review Committee for Animal Experimentation at these institutions
approved all the experimental protocols described herein (Permission Nos.
T27–113 and A30-015-4).
Real-time reverse transcription-polymerase chain reaction
(RT-PCR)
Total RNA was extracted using ISOGEN (Nippon Gene, Osaka, Japan).
Single-stranded cDNA was synthesized using M-MLV Reverse Transcriptase
(Promega). Real-time RT-PCR proceeded using SYBR-Green Master Mix
(Thermo Fisher Scientific Inc., Waltham, MA, USA) and a Real-time PCR
system (Thermo Fisher Scientific Inc.). Supplementary Table 3 shows the
primer sequences. Amounts of target mRNA were normalized relative to
that of Actb.
Immunoblotting
Proteins were extracted from mouse muscles into Tris-HCl buffer, pH 7.5,
containing 150 mM NaCl, 5 mM EDTA, 1% TritonX-100, 10 mM NaF, 2 mM
Na3VO4, 10 μM MG132, and protease inhibitor tablets (Roche Diagnostics,
Basel, Switzerland). Total protein extracts were resolved by SDS-PAGE and
transferred to PVDF membranes. PBS-Tween containing 4% Block Ace
Powder (DS Pharma Biomedical Co. Ltd., Osaka, Japan) was used to block
non-specific binding. Then, the membranes were incubated with primary
antibodies at 4 °C overnight. Chemiluminescent blot was detected using
ImmunoStar LD (Wako Pure Chemical Industries, Osaka, Japan) and signals
were quantified by densitometry. All blots or gels were derived from the
same experiment and were processed in parallel. The primary antibodies
were anti-IRS1 (Merck Millipore Burlington, MA, USA) and anti-ACTIN
(ABclonal Technology, Woburn, MA, USA).
Statistical analysis
Values were statistically evaluated by Student’s t tests using Excel-Toukei
2015 software (Social Survey Research Information Co. Ltd., Osaka, Japan),
and are expressed as means ± SEM. Statistical significance among Papp of
Asp-Gly-pTyr-Met-Pro, Asp-Gly-Tyr-Met-Pro, and Gly-Sar-Sar-Sar-Sar was
assessed by one-way analyses of variance (ANOVA) followed by Tukey post
hoc tests. Data from mice fed with non-Tg or CbR were statistically
evaluated by two-way ANOVA followed by Tukey–Kramer multiple
comparisons for post hoc analysis using Excel-Toukei 2015 software. Values
with P < 0.05 were considered significantly different.
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
DATA AVAILABILITY
The authors declare that all data supporting the findings of this study are available
within the paper and supplementary information.
Published in partnership with Beijing Technology and Business University
1. Glass, D. J. Skeletal muscle hypertrophy and atrophy signaling pathways. Int. J.
Biochem. Cell Biol. 37, 1974–1984 (2005).
2. Nikawa, T. et al. Skeletal muscle gene expression in space-flown rats. FASEB J. 18,
522–524 (2004).
3. Suzue, N. et al. Ubiquitin ligase Cbl-b downregulates bone formation through
suppression of IGF-I signaling in osteoblasts during denervation. J. Bone Miner.
Res. 21, 722–734 (2006).
4. Nakao, R. et al. Ubiquitin ligase Cbl-b is a negative regulator for insulin-like
growth factor 1 signaling during muscle atrophy caused by unloading. Mol. Cell.
Biol. 29, 4798–4811 (2009).
5. Bodine, S. C. et al. Identification of ubiquitin ligases required for skeletal muscle
atrophy. Science 294, 1704–1708 (2001).
6. Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A. & Goldberg, A. L. Atrogin-1, a
muscle-specific F-box protein highly expressed during muscle atrophy. Proc. Natl
Acad. Sci. USA 98, 14440–14445 (2001).
7. Sandri, M. et al. Foxo transcription factors induce the atrophy-related ubiquitin
ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399–412 (2004).
8. Stitt, T. N. et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle
atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol.
Cell 14, 395–403 (2004).
9. Ohno, A. et al. Structural analysis of the TKB domain of ubiquitin ligase Cbl-b
complexed with its small inhibitory peptide, Cblin. Arch. Biochem. Biophys. 594, 1–7
(2016).
10. Kawasaki, T. et al. Antihypertensive effect of valyl-tyrosine, a short chain peptide
derived from sardine muscle hydrolyzate, on mild hypertensive subjects. J. Hum.
Hypertens. 14, 519–523 (2000).
11. Sipola, M. et al. Long-term intake of milk peptides attenuates development of
hypertension in spontaneously hypertensive rats. J. Physiol. Pharmacol. 52, 745–754
(2001).
12. Majumder, K. et al. Egg-derived tri-peptide IRW exerts antihypertensive effects in
spontaneously hypertensive rats. PLoS ONE 8, e82829 (2013).
13. Adibi, S. A. The oligopeptide transporter (Pept-1) in human intestine: biology and
function. Gastroenterology 113, 332–340 (1997).
14. Palacín, M., Estévez, R., Bertran, J. & Zorzano, A. Molecular biology of mammalian
plasma membrane amino acid transporters. Physiol. Rev. 78, 969–1054 (1998).
15. Ding, L., Wang, L., Zhang, Y. & Liu, J. Transport of antihypertensive peptide RVPSL,
ovotransferrin 328-332, in human intestinal Caco-2 cell monolayers. J. Agric. Food
Chem. 63, 8143–8150 (2015).
16. Lei, L., Sun, H., Liu, D., Liu, L. & Li, S. Transport of Val-Leu-Pro-Val-Pro in human
intestinal epithelial (Caco-2) cell monolayers. J. Agric. Food Chem. 56, 3582–3586
(2008).
17. Ding, L., Wang, L., Yu, Z., Zhang, T. & Liu, J. Digestion and absorption of an egg
white ACE-inhibitory peptide in human intestinal Caco-2 cell monolayers. Int. J.
Food Sci. Nutr. 67, 111–116 (2016).
18. Hanh, V. T. et al. Effect of aging on the absorption of small peptides in spontaneously hypertensive rats. J. Agric. Food Chem. 65, 5935–5943 (2017).
19. Abe, T. et al. Soy glycinin contains a functional inhibitory sequence against
muscle-atrophy-associated ubiquitin ligase Cbl-b. Int. J. Endocrinol. 2013,
907565–907565 (2013).
20. Akama, K. et al. Seed-specific expression of truncated OsGAD2 produces GABAenriched rice grains that influence a decrease in blood pressure in spontaneously
hypertensive rats. Transgenic Res. 18, 865–876 (2009).
21. Akama, K. et al. Functional rice with tandemly repeated Cbl-b ubiquitin ligase
inhibitory pentapeptide prevents denervation-induced muscle atrophy in vivo.
Biosci. Biotechnol. Biochem. 85, 1415–1421 (2021).
22. Dörfel, M. J. & Huber, O. Modulation of tight junction structure and function by
kinases and phosphatases targeting occludin. J. Biomed. Biotechnol. 2012,
807356–807356 (2012).
23. Estaki, M., DeCoffe, D. & Gibson, D. L. Interplay between intestinal alkaline
phosphatase, diet, gut microbes and immunity. World J. Gastroenterol. 20,
15650–15656 (2014).
24. Hong, S. M., Tanaka, M., Koyanagi, R., Shen, W. & Matsui, T. Structural design of
oligopeptides for intestinal transport model. J. Agric. Food Chem. 64, 2072–2079
(2016).
25. Newstead, S. et al. Crystal structure of a prokaryotic homologue of the
mammalian oligopeptide-proton symporters, PepT1 and PepT2. EMBO J. 30,
417–426 (2011).
26. Shen, W. & Matsui, T. Current knowledge of intestinal absorption of bioactive
peptides. Food Funct. 8, 4306–4314 (2017).
npj Science of Food (2021) 25
R. Nakao et al.
10
27. Xu, F. et al. Transepithelial transport of YWDHNNPQIR and its metabolic fate with
cytoprotection against oxidative stress in human intestinal Caco-2 cells. J. Agric.
Food Chem. 65, 2056–2065 (2017).
28. Regazzo, D. et al. The (193-209) 17-residues peptide of bovine β-casein is transported through Caco-2 monolayer. Mol. Nutr. Food Res. 54, 1428–1435 (2010).
29. Chothe, P., Singh, N. & Ganapathy, V. Evidence for two different broad-specificity
oligopeptide transporters in intestinal cell line Caco-2 and colonic cell line
CCD841. Am. J. Physiol. Cell Physiol. 300, C1260–C1269 (2011).
30. Picariello, G., Ferranti, P. & Addeo, F. Use of brush border membrane vesicles to
simulate the human intestinal digestion. Food Res. Int. 88, 327–335 (2016).
31. Yamada, Y. et al. Anti-hypertensive activity of genetically modified soybean seeds
accumulating novokinin. Peptides 29, 331–337 (2008).
32. Wakasa, Y. et al. The hypocholesterolemic activity of transgenic rice seed accumulating lactostatin, a bioactive peptide derived from bovine milk
β-lactoglobulin. J. Agric. Food Chem. 59, 3845–3850 (2011).
33. Cherlyn, N. et al. Structural basis for a novel intrapeptidyl H-bond and reverse
binding of c-Cbl-TKB domain substrates. EMBO J. 27, 804–816 (2008).
34. Takagi, H. et al. Biochemical safety evaluation of transgenic rice seeds expressing
T cell epitopes of Japanese cedar pollen allergens. J. Agric. Food Chem. 54,
9901–9905 (2006).
35. Lechasseur, B. et al. Incipient malunion of an isolated humeral trochlea fracture treated with an elbow hemiarthroplasty: case report. J. Hand Surg. Am.
40, 271–275 (2015).
36. Uchida, T. et al. Reactive oxygen species upregulate expression of muscle
atrophy-associated ubiquitin ligase Cbl-b in rat L6 skeletal muscle cells. Am. J.
Physiol. Cell Physiol. 314, C721–C731 (2018).
37. Okamura, A. et al. Bile acid-regulated peroxisome proliferator-activated
receptor-α (PPARα) activity underlies circadian expression of intestinal peptide absorption transporter PepT1/Slc15a1. J. Biol. Chem. 289, 25296–25305
(2014).
38. Finkelstein, L. D. & Shimizu, Y. Role of phosphoinositide 3-kinase and the Cbl
adaptor protein in coupling the alpha4beta1 integrin to mitogen-activated
protein kinase signalling. Biochem. J. 345, 385–392 (2000).
39. Norman, A. W. & Henry, H. L. Hormones 3rd edn, Ch. 7 (Academic Press, 2015).
40. Ogawa, M. et al. Mutants for rice storage proteins: 2. Isolation and characterization of protein bodies from rice mutants. Theor. Appl. Genet. 78, 305–310
(1989).
41. Ogawa, M. et al. Purification of protein body-I of rice seed and its polypeptide
composition. Plant Cell Physiol. 28, 1517–1527 (1987).
42. Takagi, H. et al. Oral immunotherapy against a pollen allergy using a seed-based
peptide vaccine. Plant Biotechnol. J. 3, 521–533 (2005).
43. Shen, W. & Matsui, T. Intestinal absorption of small peptides: a review. Int. J. Food
Sci. Tech. 54, 1942–1948 (2019).
44. Wang, L., Ding, L., Du, Z., Yu, Z. & Liu, J. Hydrolysis and transport of egg whitederived peptides in Caco-2 cell monolayers and everted rat sacs. J. Agric. Food
Chem. 67, 4839–4848 (2019).
45. Takeda, J., Park, H.-Y., Kunitake, Y., Yoshiura, K. & Matsui, T. Theaflavins, dimeric
catechins, inhibit peptide transport across Caco-2 cell monolayers via downregulation of AMP-activated protein kinase-mediated peptide transporter PEPT1.
Food Chem. 138, 2140–2145 (2013).
46. Ma, K., Hu, Y. & Smith, D. E. Peptide transporter 1 is responsible for intestinal
uptake of the dipeptide glycylsarcosine: studies in everted jejunal rings from
wild-type and Pept1 null mice. J. Pharm. Sci. 100, 767–774 (2011).
47. Ding, L. et al. Transport of egg white ace-inhibitory peptide, Gln-Ile-Gly-Leu-Phe,
in human intestinal Caco-2 cell monolayers with cytoprotective effect. J. Agric.
Food Chem. 62, 3177–3182 (2014).
npj Science of Food (2021) 25
Published in partnership with Beijing Technology and Business University
ACKNOWLEDGEMENTS
This study was supported by JSPS Research Fellowship for Young Scientists to W.S.
(No. 19J20948), JSPS KAKENHI to T.N. (JP18H04981 and JP19H04054) from the
Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and
AMED-CREST to T.N. (JP19gm0810009h0104). The authors thank Arisa Ochi, Hina
Ishikawa, and Yuki Nomura (Tokushima University) for technical assistance.
AUTHOR CONTRIBUTIONS
R.N., W.S., Y.Sh., K.K., K.O., A.O., T.U., M.T., K.A., T.M., and T.N. designed the study
protocol. R.N., W.S., Y.Sh., K.K., Y.Sa., A.U., K.O., M.N., M.T., K.A., and T.M. conducted
experiments. R.N., W.S., Y.Sh., K.K., Y.Sa., K.O., A.O., M.T., K.A, T.M., and T.N. analyzed
data. R.N., W.S., Y.Sa., M.T., K.A, T.M., and T.N. contributed to writing the manuscript.
All authors read and approved the final version of the manuscript.
COMPETING INTERESTS
The authors declare no competing interests.
ADDITIONAL INFORMATION
Supplementary information The online version contains supplementary material
available at https://doi.org/10.1038/s41538-021-00108-0.
Correspondence and requests for materials should be addressed to T.N.
Reprints and permission information is available at http://www.nature.com/
reprints
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims
in published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the article’s
Creative Commons license and your intended use is not permitted by statutory regulation or
exceeds the permitted use, you will need to obtain permission directly from the copyright
holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
© The Author(s) 2021
...